Michael Pilot Email Address

Senior Finance Leader Healthcare Business Goup Global Operations

LifeCell is now an Acelity company! Acelity is a global market leader in advanced wound therapeutics and regenerative medicine, offering innovative solutions from the hospital to home that improve the lives of patients in more than 80 countries. Our mission is to change the practice of medicine with solutions that speed healing, create economic value and improve patients' lives. We are the undisputed leader in negative pressure wound therapy, the number one provider of regenerative tissue products used for breast reconstruction and hernia repair, and the market leader in collagen dressings. Acelity is headquartered in San Antonio, Texas, with more than 5,800 employees around the globe.\r\n\r\nLifeCell is focused on the development and commercialization of regenerative and reconstructive acellular tissue matrices for use in general and reconstructive surgical procedures to repair soft tissue defects, as well as autologous fat grafting solutions. \r\n\r\nThe LifeCell portfolio began with ALLODERM(tm) Regenerative Tissue Matrix, which launched in 1994, and expanded with the launch of STRATTICE(tm) Reconstructive Tissue Matrix in 2008, the same year that Kinetic Concepts, Inc. (KCI) acquired LifeCell. In 2012, LifeCell further expanded its portfolio with the launch of ALLODERM(tm) Ready to Use. In June 2013, LifeCell introduced the REVOLVE(tm) System to offer fast and efficient fat transfer processing for use in a range of aesthetic and reconstructive procedures. In 2014, KCI's parent company announced that KCI, LifeCell and Systagenix would operate under one global medical technology brand known as Acelity.

Leverage strong business and financial acumen to develop strategies aligned with overall corporate objectives that enhance top/bottom-line performance, operational efficiency, organization and customer service. Excel in expanding company presence via organic and M&A activity and delivering dynamic leadership in turnaround, integration, startup, and divesture settings. Significant experience in leading the Financial Forecasting and Analysis (FP&A) function for large sales regions as well as driving financial performance thru operational leadership in both manufacturing and field distribution settings. Proven success managing full P&L's, internal controls, reporting and compliance of $100M+ publicly-traded business units. Select Career Highlights •Appointed team lead for a nationwide project to optimize Stryker Orthopaedics’ field inventory levels and reduce adjustment costs without negatively impacting service levels; accomplished a $10M division savings for 2011. •Managed GI absorption of core flexible scope technology into a $900M Endoscopy division (Medical Equipment/ Medical Devices); propelled division to exceed cash flow and operating budget targets during leadership tenure. •Designed and deployed a customized activity-based costing and resource management system for Electromark that yielded a 320% gross margin improvement, elevating the bottom line from $1.9M to $6M+ after implementation. •Partnered with Stryker Orthopaedics’ area branch operations to develop plans to restructure the distribution model by adding key resources to lift performance; reduced overall courier spend of areas by $650K+ annually. Core strengths: Strategic Planning – Financial Reporting – Profit Optimization – Cash Flow Management– Budgeting – Forecasting – Reporting & Analysis – Change Management – Corporate Governance – SOX/Regulatory Compliance – Auditing & Internal Controls – Inventory Management – M&A/Integrations – System Implementations – Negotiations